Concepedia

Emilya Ventriglia

EV

Statistics

Publications

5

Citations

153

H-Index

5

Active since

2022

Affiliations

National Institute on Drug Abuse(Current)

Johns Hopkins Medicine

Johns Hopkins University

Universitat de Barcelona

Institut d'Investigació Biomédica de Bellvitge

Emilya Ventriglia is an author at National Institute on Drug Abuse specializing in medicine, opioid pharmacology, and neuroscience.

ORCID

Publications per year

2022–2023

5

Publications

5

Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability

Marjorie R. Levinstein, Meghan L. Carlton, Tommaso Di Ianni et al. · Biological Psychiatry · 2022 · 53 citations

, , +14

In vivo photopharmacology with light-activated opioid drugs

Shannan P. McClain, Xiang Ma, Desiree A. Johnson et al. · Neuron · 2023 · 37 citations · Full text

, , +16

Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone

Marjorie R. Levinstein, Paulo Alexandre de Oliveira, Nil Casajuana-Martín et al. · Molecular Psychiatry · 2023 · 27 citations · Full text

, , +15

A CRE/DRE dual recombinase transgenic mouse reveals synaptic zinc–mediated thalamocortical neuromodulation

Stylianos Kouvaros, Brandon Bizup, Óscar Solís et al. · Science Advances · 2023 · 23 citations · Full text

, , +17

Essential role of P-glycoprotein in the mechanism of action of oliceridine

Emilya Ventriglia, Arianna Rizzo, Juan L. Gomez et al. · Neuropsychopharmacology · 2022 · 13 citations · Full text

, , +7

1–5 of 5